For today’s bulletin, we take a look at our latest STRONG BUY and BUY upgrades and focus on one of our top upgrades for the day, AstraZeneca $AZN. We also provide a link to download a FREE STOCK REPORT on the company. Overvaluation has declined below 60% and therefore we have ended our latest Valuation … Read more
This week, we provide top-five ranked VE data for our Basic Materials Sector stocks. We take a look at our latest data on Chemours Company $CC and provide a free download link for our stock report on the company. VALUATION WATCH: Overvalued stocks now make up 61.86% of our stocks assigned a valuation and 26.49% … Read more
This week, we provide top-five ranked VE data for our Medical Sector stocks. We take a look at our latest data on JPMorgan Chase $JPM and provide a free download link for our stock report on the company. Because overvaluation has crept up again, we now have another Valuation Watch. VALUATION WATCH: Overvalued stocks now … Read more
This week, we provide top-five ranked VE data for our Medical stocks. We take a look at our latest data on Twitter TWTR$ and provide a free download link for our stock report on the company. VALUATION WATCH: Overvalued stocks now make up 61.01% of our stocks assigned a valuation and 26.54% of those equities … Read more
This week, we provide top-five ranked VE data for our Health Care stocks. We take a look at our latest data on IBM $IBM. We currently have an overvaluation watch underway. VALUATION WATCH: Overvalued stocks now make up 61.45% of our stocks assigned a valuation and 25.36% of those equities are calculated to be overvalued … Read more
This week, we provide top-five ranked VE data for our Medical stocks. We take a look at our latest data on Intel $INTC. We currently have an overvaluation watch underway. VALUATION WATCH: Overvalued stocks now make up 64.57% of our stocks assigned a valuation and 31.59% of those equities are calculated to be overvalued by … Read more